We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+12.48%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.2B
AUM Growth
+$1.6B
Cap. Flow
+$244M
Cap. Flow %
1.85%
Top 10 Hldgs %
17.23%
Holding
2,008
New
175
Increased
901
Reduced
772
Closed
138

Sector Composition

Rank Sector Weight
1 Technology 24.71%
2 Healthcare 9.61%
3 Consumer Discretionary 8.52%
4 Financials 7.9%
5 Industrials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTF
851
Franklin Limited Duration Income Trust
FTF
$233M
$1.99M 0.02%
320,280
-33,419
-9% -$204K
KMX icon
852
CarMax
KMX
$8.26B
$1.98M 0.02%
25,811
+7,287
+39% +$490K
MRTX
853
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.97M 0.01%
33,462
+2,557
+8% +$144K
MHK icon
854
Mohawk Industries
MHK
$9.22B
$1.96M 0.01%
18,948
+7,380
+64% +$646K
SMCI icon
855
Super Micro Computer
SMCI
$20.1B
$1.95M 0.01%
68,500
+29,560
+76% +$819K
DRI icon
856
Darden Restaurants
DRI
$24.4B
$1.94M 0.01%
11,836
+7,674
+184% +$1.16M
WIP icon
857
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$476M
$1.93M 0.01%
46,122
+6,602
+17% +$261K
AIF
858
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$1.93M 0.01%
138,148
+22,647
+20% +$298K
KRC icon
859
Kilroy Realty
KRC
$4.42B
$1.92M 0.01%
48,268
+585
+1% +$19.3K
BNTX icon
860
BioNTech
BNTX
$23.5B
$1.92M 0.01%
18,199
-853
-4% -$86K
PACB icon
861
Pacific Biosciences
PACB
$370M
$1.92M 0.01%
195,377
+43,021
+28% +$352K
SAH icon
862
Sonic Automotive
SAH
$2.61B
$1.91M 0.01%
+34,058
New +$1.71M
LEGN icon
863
Legend Biotech
LEGN
$4.01B
$1.9M 0.01%
+31,628
New +$2M
MTB icon
864
M&T Bank
MTB
$36.2B
$1.9M 0.01%
13,848
+2,602
+23% +$327K
BWG
865
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
$1.89M 0.01%
226,119
-23,669
-9% -$181K
APLS
866
DELISTED
Apellis Pharmaceuticals
APLS
$1.89M 0.01%
31,570
-9,535
-23% -$484K
AWF
867
AllianceBernstein Global High Income Fund
AWF
$872M
$1.89M 0.01%
186,413
-2,601
-1% -$25.2K
WTW icon
868
Willis Towers Watson
WTW
$32B
$1.88M 0.01%
7,789
+2,219
+40% +$513K
IT icon
869
Gartner
IT
$11.7B
$1.88M 0.01%
4,162
+2,624
+171% +$1.05M
NTLA icon
870
Intellia Therapeutics
NTLA
$1.67B
$1.87M 0.01%
61,194
-10,486
-15% -$301K
CAG icon
871
Conagra Brands
CAG
$7.23B
$1.86M 0.01%
65,054
+1,608
+3% +$45.1K
NVCR icon
872
NovoCure
NVCR
$1.91B
$1.85M 0.01%
123,949
+106,452
+608% +$1.42M
XBI icon
873
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.84M 0.01%
20,658
IBKR icon
874
Interactive Brokers
IBKR
$39.8B
$1.84M 0.01%
88,892
+67,524
+316% +$1.38M
SBAC icon
875
SBA Communications
SBAC
$19.5B
$1.84M 0.01%
7,253
+452
+7% +$101K

Similar funds

Guggenheim Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Guggenheim Capital held 2,008 positions worth $13.2B, up 14% from $11.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q4 2023 filing shows 175 new, 901 increased, 772 reduced and 138 closed positions. Its largest new stake was Talos Energy: 326,375 shares worth $4.64M. The largest sale was Seagen Inc. Common Stock, an estimated $15.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q4 2023 buy was Talos Energy: 326,375 shares worth $4.64M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $37.9M increase.
  • Guggenheim Capital's biggest Q4 2023 reduction was Apple, cutting an estimated $12M.
  • Guggenheim Capital fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $15.6M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $13.2B portfolio in Q4 2023.
  • Guggenheim Capital opened 175 new positions and closed 138 in Q4 2023.
  • Guggenheim Capital's portfolio value rose 14% quarter-over-quarter to $13.2B.

Based on Guggenheim Capital's 13F filing for Q4 2023, filed 14 Feb 2024.